Firm record

Baxter International

◇Private·United States·GICS Pharmaceuticals & Biotechnology·LEI J5OIVXX3P24RJRW5CK77

This is a partial record assembled from open public datasets (WBA, Net Zero Tracker, SBTi, TPI, CDP). Reverberate's deeper extraction layer covers a curated cohort of firms — see the full directory for firms with verified financial + multi-year disclosure depth.

Reported emissions2 years

	2025	2024	unit
Scope 1	—	324.0k	tCO2e
Scope 3	—	3.8M	tCO2e

Partial profile

We haven't fully researched Baxter International yet.

Request a full evidence-chained profile — we'll dig into their carbon, nature, social & water disclosure, find their facilities and sources, and email you when it's ready.

We’ll only use your email to notify you about this request.

Climate action evidence

1 record · 1 source

Carbon credits retired

No retirement evidence on file (third-party or self-reported).

Renewable electricity

117,337 MWh

30% of total electricity · EPA Green Power Partnership snapshotsource ↗

Sources

· EPA Green Power Partnership

Registry retirements are direct evidence; commitments are forward-looking pledges. EPA snapshot covers FY2019–FY2020.

Targets & commitments6

Source	Type	Scope	Base	Target year	Value	Status
wba	Near-term	S3	—	—	—	—
wba	Near-term	S1 + 2	2020	2030	467250	Not validated
wba	Long-term	S1 + 2	—	2040	—	Not validated
wba	Long-term	S3	—	—	—	—
nzt	net_zero	Scope 1 + 2	2005	2040	—	In corporate strategy
nzt	near_term	Scope 1 + 2	2020	2030	25%	In corporate strategy

Identifiers

lei	J5OIVXX3P24RJRW5CK77
isin	US0718131099
wikidata_qid	Q761965
wba_company_id	PT_00222
nzt_id	COM-0842
Reverberate ID	9f815163…